Potential Use of Coronary Artery Calcium Progression to Guide the Management of Patients at Risk for Coronary Artery Disease Events

被引:8
|
作者
John W. McEvoy
Michael J. Blaha
Khurram Nasir
Roger S. Blumenthal
Steven R. Jones
机构
[1] Johns Hopkins Ciccarone Center for the Prevention of Heart Disease,
关键词
Coronary Artery Calcium; Cardiac CT; Primary Prevention; Progression;
D O I
10.1007/s11936-011-0154-5
中图分类号
学科分类号
摘要
Subclinical coronary artery disease (CAD) is widespread and under-diagnosed. Preventive efforts are required to reduce the burden of this disease and its complications. Imaging of coronary artery calcium (CAC) with cardiac computed tomography is highly specific for the diagnosis of subclinical CAD and can also facilitate treatment decisions in preventive cardiology. Indeed, CAC testing has been recommended by the American Heart Association for asymptomatic patients at intermediate risk for future cardiac events (as defined by clinical risk factors) to refine existing risk estimates. However, the optimal follow-up of those patients who have already undergone CAC testing remains unclear, particularly with regards to repeat CAC testing. The existing literature points to two major considerations for the use of CAC progression in the management of subclinical CAD. On one hand, CAC progression has been used as a surrogate marker to test the efficacy of cardiac preventive medications in halting or regressing CAD. To date, study results have been mostly disappointing and CAC progression appears resistant to medications such as statins. On the other hand, however, CAC progression has potential as a clinical indicator of underlying CAD activity. This may facilitate optimization or up-titration of preventive medications by using CAC progression as a marker of subclinical disease activity. We believe that the data, thus far, argues against the use of a CAC progression as a clinical surrogate marker of preventive therapy efficacy. Further studies with non-statin medications and with concomitant outcome data are needed. However, CAC progression has potential for monitoring subclinical CAD in some patients and may facilitate treatment decisions. In this review we will provide recommendations for repeat CAC testing and discuss when repeat CAC testing may be helpful to assess coronary artery disease progression.
引用
收藏
页码:69 / 80
页数:11
相关论文
共 50 条
  • [1] Is There a Role for Coronary Artery Calcium Scoring for Management of Asymptomatic Patients at Risk for Coronary Artery Disease?
    Blaha, Michael J.
    Silverman, Michael G.
    Budoff, Matthew J.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2014, 7 (02) : 398 - 408
  • [2] The use of coronary artery calcium scanning in detection and risk stratification of coronary artery disease
    Parma, Zofia
    COR ET VASA, 2015, 57 (06) : E433 - E438
  • [3] Coronary Artery Calcium Progression and Residual Risk
    Hecht, Harvey
    Chandrashekhar, Y.
    Narula, Jagat
    JACC-CARDIOVASCULAR IMAGING, 2016, 9 (12) : 1477 - 1479
  • [4] Relationship Between Coronary Artery Calcium and Atherosclerosis Progression Among Patients With Suspected Coronary Artery Disease
    Hollenberg, Emma J.
    Lin, Fay
    Blaha, Michael J.
    Budoff, Matthew J.
    van den Hoogen, Inge J.
    Gianni, Umberto
    Lu, Yao
    Bax, A. Maxim
    van Rosendael, Alexander R.
    Tantawy, Sara W.
    Andreini, Daniele
    Cademartiri, Filippo
    Chinnaiyan, Kavitha
    Choi, Jung Hyun
    Conte, Edoardo
    Goncalves, Pedro de Araujo
    Hadamitzky, Martin
    Maffei, Erica
    Pontone, Gianluca
    Shin, Sanghoon
    Kim, Yong-Jin
    Lee, Byoung Kwon
    Chun, Eun Ju
    Sung, Ji Min
    Gimelli, Alessia
    Lee, Sang-Eun
    Bax, Jeroen J.
    Berman, Daniel S.
    Sellers, Stephanie L.
    Leipsic, Jonathon A.
    Blankstein, Ron
    Narula, Jagat
    Chang, Hyuk-Jae
    Shaw, Leslee J.
    JACC-CARDIOVASCULAR IMAGING, 2022, 15 (06) : 1063 - 1074
  • [5] Coronary artery calcium score, risk factors, and incident coronary heart disease events
    Church, Timothy S.
    Levine, Benjamin D.
    McGuire, Darren K.
    LaMonte, Michael J.
    FitzGerald, Shannon J.
    Cheng, Yiling J.
    Kimball, Thomas E.
    Blair, Steven N.
    Gibbons, Larry W.
    Nichaman, Milton Z.
    ATHEROSCLEROSIS, 2007, 190 (01) : 224 - 231
  • [6] The Prognostic Value of Coronary Artery Calcium Scoring for Future Coronary Artery Events in Patients with Chronic Kidney Disease
    Miki, Takashi
    Sakuragi, Satoru
    Yamada, Keiji
    Tanimoto, Masafumi
    Fujiwara, Takashi
    Otsuka, Hiroaki
    Yamamoto, Kazuhiko
    Kawamoto, Kenji
    Tanakaya, Machiko
    Katayama, Yusuke
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : S54 - S54
  • [7] CORONARY ARTERY CALCIUM PROGRESSION AS A STRONG PREDICTOR OF ADVERSE FUTURE CORONARY EVENTS
    Zeb, Irfan
    Li, Dong
    Nasir, Khurram
    Mao, Songshou
    Budoff, Matthew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E984 - E984
  • [8] RISK FACTORS MANAGEMENT IN CORONARY ARTERY DISEASE PATIENTS
    Stoica, S.
    Rus, A.
    Gaita, D.
    ATHEROSCLEROSIS, 2022, 355 : E190 - E190
  • [9] Coronary Calcium Score as a Predictor for Coronary Artery Disease and Cardiac Events in Japanese High-Risk Patients
    Yamamoto, Hideya
    Ohashi, Norihiko
    Ishibashi, Ken
    Utsunomiya, Hiroto
    Kunita, Eiji
    Oka, Toshiharu
    Horiguchi, Jun
    Kihara, Yasuki
    CIRCULATION JOURNAL, 2011, 75 (10) : 2424 - 2431
  • [10] Coronary artery calcium, coronary artery disease, and diabetes
    Mielke, CH
    Shields, JP
    Broemeling, LD
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 53 (01) : 55 - 61